PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
GNOM vs. VDIV.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

GNOM vs. VDIV.DE

Last updated Apr 2, 2026

Compare and contrast key facts about Global X Genomics & Biotechnology ETF (GNOM) and VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (VDIV.DE).

GNOM and VDIV.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GNOM is a passively managed fund by Global X that tracks the performance of the Solactive Genomics Index. It was launched on Apr 5, 2019. VDIV.DE is a passively managed fund by VanEck that tracks the performance of the Morningstar Developed Markets Large Cap Dividend Leaders Screened Select Index. It was launched on May 23, 2016. Both GNOM and VDIV.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

GNOM vs. VDIV.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X Genomics & Biotechnology ETF (GNOM) and VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (VDIV.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GNOM vs. VDIV.DE - Yearly Performance Comparison

2026 (YTD)2025202420232022202120202019
GNOM
Global X Genomics & Biotechnology ETF		-2.79%18.65%-15.99%-8.63%-36.27%-15.93%51.52%1.56%
VDIV.DE
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF		7.88%40.61%9.06%14.99%9.11%17.83%-2.30%5.94%
Different Trading Currencies

GNOM is traded in USD, while VDIV.DE is traded in EUR. To make them comparable, the VDIV.DE values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, GNOM achieves a -2.79% return, which is significantly lower than VDIV.DE's 7.88% return.

GNOM

1D
1.02%
1M
-6.22%
YTD
-2.79%
6M
12.23%
1Y
44.15%
3Y*
-3.13%
5Y*
-13.13%
10Y*
—

VDIV.DE

1D
0.19%
1M
-1.14%
YTD
7.88%
6M
16.05%
1Y
32.75%
3Y*
23.11%
5Y*
17.55%
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Global X Genomics & Biotechnology ETF

VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF

Often compared with GNOM:
GNOM vs. ARKGGNOM vs. IDNAGNOM vs. IBBGNOM vs. IBBQGNOM vs. TMQGNOM vs. FTECGNOM vs. SMH
Often compared with VDIV.DE:
VDIV.DE vs. SCHDVDIV.DE vs. ISPA.DEVDIV.DE vs. VHYL.ASVDIV.DE vs. VHYD.LVDIV.DE vs. JEPG.LVDIV.DE vs. FUSD.LVDIV.DE vs. JEPQ

GNOM vs. VDIV.DE - Expense Ratio Comparison

GNOM has a 0.50% expense ratio, which is higher than VDIV.DE's 0.38% expense ratio.

GNOM
Global X Genomics & Biotechnology ETF
VDIV.DE
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF

Return for Risk

GNOM vs. VDIV.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GNOM
GNOM Risk / Return Rank: 7373
Overall Rank
GNOM Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
GNOM Sortino Ratio Rank: 7777
Sortino Ratio Rank
GNOM Omega Ratio Rank: 6868
Omega Ratio Rank
GNOM Calmar Ratio Rank: 7878
Calmar Ratio Rank
GNOM Martin Ratio Rank: 6969
Martin Ratio Rank
VDIV.DE
VDIV.DE Risk / Return Rank: 8585
Overall Rank
VDIV.DE Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
VDIV.DE Sortino Ratio Rank: 8383
Sortino Ratio Rank
VDIV.DE Omega Ratio Rank: 9090
Omega Ratio Rank
VDIV.DE Calmar Ratio Rank: 7878
Calmar Ratio Rank
VDIV.DE Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNOM vs. VDIV.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (VDIV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

GNOMVDIV.DEDifference

Sharpe ratio

Return per unit of total volatility

1.43

2.18

-0.75

Sortino ratio

Return per unit of downside risk

2.04

2.70

-0.66

Omega ratio

Gain probability vs. loss probability

1.26

1.45

-0.19

Calmar ratio

Return relative to maximum drawdown

2.25

2.74

-0.49

Martin ratio

Return relative to average drawdown

7.43

15.10

-7.67

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GNOM vs. VDIV.DE - Sharpe Ratio Comparison

The current GNOM Sharpe Ratio is 1.43, which is lower than the VDIV.DE Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of GNOM and VDIV.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

GNOMVDIV.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.43

2.18

-0.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.39

1.21

-1.60

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

0.87

-1.00

Correlation

The correlation between GNOM and VDIV.DE is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GNOM vs. VDIV.DE - Dividend Comparison

GNOM's dividend yield for the trailing twelve months is around 1.41%, less than VDIV.DE's 3.33% yield.

TTM20252024202320222021202020192018
GNOM
Global X Genomics & Biotechnology ETF		1.41%1.37%0.00%0.00%0.00%0.03%0.14%0.00%0.00%
VDIV.DE
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF		3.33%3.58%4.19%4.97%4.56%3.97%4.11%4.35%0.91%

Drawdowns

GNOM vs. VDIV.DE - Drawdown Comparison

The maximum GNOM drawdown since its inception was -75.00%, which is greater than VDIV.DE's maximum drawdown of -37.84%. Use the drawdown chart below to compare losses from any high point for GNOM and VDIV.DE.

Loading graphics...

Drawdown Indicators

GNOMVDIV.DEDifference

Max Drawdown

Largest peak-to-trough decline

-75.00%

-35.93%

-39.07%

Max Drawdown (1Y)

Largest decline over 1 year

-18.17%

-13.81%

-4.36%

Max Drawdown (5Y)

Largest decline over 5 years

-72.29%

-15.12%

-57.17%

Current Drawdown

Current decline from peak

-59.83%

-0.58%

-59.25%

Average Drawdown

Average peak-to-trough decline

-40.12%

-4.25%

-35.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.51%

1.98%

+3.53%

Volatility

GNOM vs. VDIV.DE - Volatility Comparison

Global X Genomics & Biotechnology ETF (GNOM) has a higher volatility of 10.76% compared to VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (VDIV.DE) at 3.72%. This indicates that GNOM's price experiences larger fluctuations and is considered to be riskier than VDIV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

GNOMVDIV.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.76%

3.72%

+7.04%

Volatility (6M)

Calculated over the trailing 6-month period

19.71%

8.04%

+11.67%

Volatility (1Y)

Calculated over the trailing 1-year period

31.21%

15.01%

+16.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.65%

14.32%

+19.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.30%

17.49%

+16.81%